Animal Ultrasound Market Size, Share & Trends Analysis Report By Solution (Equipment, Accessories/Consumables, PACS), By Animal (Small, Large), By Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
Description
Animal Ultrasound Market Summary
The global animal ultrasound market size was estimated at USD 539.39 million in 2025 and is projected to reach USD 998.76 million by 2033, growing at a CAGR of 8.19% from 2026 to 2033. Some of the key factors driving market growth are growing research initiatives & breakthroughs, expanding applications of ultrasound in the veterinary sector, rising adoption of pet insurance, and increasing critical collaboration in the industry.
Growing research initiatives and technological breakthroughs are significantly accelerating the market by enhancing diagnostic precision, expanding therapeutic applications, and supporting wider clinical adoption. Increasing R&D investment by universities, veterinary institutes, and animal health companies is leading to innovations that make ultrasound systems more accurate, portable, and cost-efficient. A major advancement is the rapid adoption of focused ultrasound (FUS), which extends ultrasound use beyond diagnostics into noninvasive therapeutic procedures. FUS shows strong potential in oncology, pain management, soft-tissue repair, neuromodulation, and metabolic diseases, driving demand for advanced systems capable of high-energy, image-guided interventions. As research transitions into routine practice, veterinary hospitals increasingly invest in upgraded ultrasound platforms, training, and workflow integration.
In addition, the expanding use of ultrasound across all tiers of veterinary practice is a major growth catalyst, signaling its transition from a specialized tool to a standard diagnostic modality. More than half of clinics now own ultrasound systems, and routine use for abdominal pain, respiratory issues, reproductive monitoring, and emergency triage is rising steadily. This shift drives recurring demand for upgraded hardware, software enhancements, and practitioner training. Clinical applications are diversifying beyond abdominal and thoracic imaging into cardiology, oncology, musculoskeletal injuries, and point-of-care emergency diagnostics. As ultrasound becomes integral to general practice and specialty care workflows, it boosts recurring revenue from device purchases, service contracts, consumables, and education programs, expanding long-term market adoption.
Global Animal Ultrasound Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal ultrasound market report based on animal, solution, type, technology, application, end use, and region:
The global animal ultrasound market size was estimated at USD 539.39 million in 2025 and is projected to reach USD 998.76 million by 2033, growing at a CAGR of 8.19% from 2026 to 2033. Some of the key factors driving market growth are growing research initiatives & breakthroughs, expanding applications of ultrasound in the veterinary sector, rising adoption of pet insurance, and increasing critical collaboration in the industry.
Growing research initiatives and technological breakthroughs are significantly accelerating the market by enhancing diagnostic precision, expanding therapeutic applications, and supporting wider clinical adoption. Increasing R&D investment by universities, veterinary institutes, and animal health companies is leading to innovations that make ultrasound systems more accurate, portable, and cost-efficient. A major advancement is the rapid adoption of focused ultrasound (FUS), which extends ultrasound use beyond diagnostics into noninvasive therapeutic procedures. FUS shows strong potential in oncology, pain management, soft-tissue repair, neuromodulation, and metabolic diseases, driving demand for advanced systems capable of high-energy, image-guided interventions. As research transitions into routine practice, veterinary hospitals increasingly invest in upgraded ultrasound platforms, training, and workflow integration.
In addition, the expanding use of ultrasound across all tiers of veterinary practice is a major growth catalyst, signaling its transition from a specialized tool to a standard diagnostic modality. More than half of clinics now own ultrasound systems, and routine use for abdominal pain, respiratory issues, reproductive monitoring, and emergency triage is rising steadily. This shift drives recurring demand for upgraded hardware, software enhancements, and practitioner training. Clinical applications are diversifying beyond abdominal and thoracic imaging into cardiology, oncology, musculoskeletal injuries, and point-of-care emergency diagnostics. As ultrasound becomes integral to general practice and specialty care workflows, it boosts recurring revenue from device purchases, service contracts, consumables, and education programs, expanding long-term market adoption.
Global Animal Ultrasound Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal ultrasound market report based on animal, solution, type, technology, application, end use, and region:
- Animal Outlook (Revenue, USD Million, 2021 - 2033)
- Small Animals
- Large Animals
- Solution Outlook (Revenue, USD Million, 2021 - 2033)
- Equipment
- Console/Cart-Based Ultrasound
- Portable/Handheld Ultrasound
- Accessories/Consumables
- PACS
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- 2-D Ultrasound Imaging
- 3-D/4-D Ultrasound Imaging
- Doppler Imaging
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Digital Imaging
- Contrast Imaging
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Orthopedics
- Cardiology
- Oncology
- Abdominal
- Other Applications
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Veterinary Hospitals & Clinics
- Other End-Use
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
- Qatar
- Oman
Table of Contents
150 Pages
- Chapter 1. Clinical laboratory services market: Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Test Type Method
- 1.1.1.2. Service Provider Segment
- 1.1.1.3. Application Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR’s Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
- Chapter 2. Clinical laboratory services market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Test Type Snapshot
- 2.3. Service Provider Snapshot
- 2.4. Application Snapshot
- 2.5. Competitive Landscape Snapshot
- Chapter 3. Clinical laboratory services market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Technological advancements in the field of clinical testing
- 3.4.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
- 3.4.3. Introduction of novel solutions
- 3.4.4. Outbreak of COIVD-19 pandemic
- 3.5. Market Restraint Analysis
- 3.5.1. Presence of stringent regulatory framework
- 3.6. Porter’s Five Forces Analysis
- 3.7. PESTLE Analysis
- 3.8. Pipeline Analysis
- Chapter 4. Clinical laboratory services market: Test Type Estimates & Trend Analysis
- 4.1. Clinical laboratory services market: Test Type Movement Analysis
- 4.2. Genetic testing
- 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3. Clinical chemistry
- 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.2. Routine chemistry testing
- 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.3. Therapeutic drug monitoring testing
- 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.4. Endocrinology chemistry testing
- 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.5. Specialized chemistry testing
- 4.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.6. Other clinical chemistry testing
- 4.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Medical microbiology & cytology
- 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Infectious disease testing
- 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Transplant diagnostic testing
- 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Other microbiology testing
- 4.4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Hematology testing
- 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Immunology testing
- 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Cytology testing
- 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Drug of abuse testing
- 4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.9. Other esoteric tests
- 4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Clinical laboratory services market: Service Provider Estimates & Trend Analysis
- 5.1. Clinical laboratory services market: Service Provider Movement Analysis
- 5.2. Hospital-based laboratories
- 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3. Stand-alone laboratories
- 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Clinic-based laboratories
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Clinical laboratory services market: Application Estimates & Trend Analysis
- 6.1. Clinical laboratory services market: Service Provider Movement Analysis
- 6.2. Bioanalytical & lab chemistry services
- 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3. Toxicology testing services
- 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Cell & gene therapy related services
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Preclinical & clinical trial related services
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Drug discovery & development related services
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Other clinical laboratory services
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Clinical laboratory services market: Regional Business Analysis
- 7.1. Regional Market Snapshot
- 7.2. North America
- 7.2.1. North America Clinical laboratory services market Estimates And Forecast, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. Reimbursement Scenario
- 7.2.2.5. U.S. Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Reimbursement Scenario
- 7.2.3.5. Canada Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Reimbursement Scenario
- 7.2.4.5. Mexico Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. Reimbursement Scenario
- 7.3.2.5. UK Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Reimbursement Scenario
- 7.3.3.5. Germany Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.4. Spain
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Reimbursement Scenario
- 7.3.4.5. Spain Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.5. France
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Reimbursement Scenario
- 7.3.5.5. France Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.6. Italy
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Reimbursement Scenario
- 7.3.6.5. Italy Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1.
- 7.3.7.2. Key Country Dynamics
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Denmark Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Reimbursement Scenario
- 7.3.8.5. Sweden Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Reimbursement Scenario
- 7.3.9.5. Norway Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia-Pacific Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Reimbursement Scenario
- 7.4.2.5. Japan Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Reimbursement Scenario
- 7.4.3.5. China Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Reimbursement Scenario
- 7.4.4.5. India Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Reimbursement Scenario
- 7.4.5.5. South Korea Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.6. Thailand
- 7.4.6.1. Thailand Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.6.2. Key Country Dynamics
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. Thailand Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.4.7. Australia
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Reimbursement Scenario
- 7.4.7.5. Australia Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. Brazil Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.5.3. Colombia
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Colombia Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.5.4. Peru
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement Scenario
- 7.5.4.5. Peru Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.5.5. Argentina
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Reimbursement Scenario
- 7.5.5.5. Argentina Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. South Africa Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Saudi Arabia Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. UAE Clinical laboratory services market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Kuwait Clinical laboratory services market, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. Laboratory Corporation of America Holdings (LabCorp)
- 8.4.1.1. Company Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. QIAGEN
- 8.4.2.1. Company Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Eurofins Scientific
- 8.4.3.1. Company Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Quest Diagnostics Incorporated
- 8.4.4.1. Company Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. OPKO Health, Inc.
- 8.4.5.1. Company Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Siemens Healthineers AG
- 8.4.6.1. Company Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. NeoGenomics Laboratories.
- 8.4.7.1. Company Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Fresenius Medical Care.
- 8.4.8.1. Company Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. ARUP Laboratories.
- 8.4.9.1. Company Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Sonic Healthcare Limited
- 8.4.10.1. Company Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.11. Charles River Laboratories.
- 8.4.11.1. Company Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Strategic Initiatives
- 8.4.12. SYNLAB International
- 8.4.12.1. Company Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Strategic Initiatives
- 8.4.13. Mayo Clinic Laboratories
- 8.4.13.1. Company Overview
- 8.4.13.2. Financial Performance
- 8.4.13.3. Product Benchmarking
- 8.4.13.4. Strategic Initiatives
- 8.4.14. Unilabs
- 8.4.14.1. Company Overview
- 8.4.14.2. Financial Performance
- 8.4.14.3. Product Benchmarking
- 8.4.14.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
